Recruiting
Phase 2

MZE829

Sponsor:

Maze Therapeutics

Code:

NCT06830629

Conditions

Proteinuric Kidney Disease

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MZE829

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-02. This information was provided to ClinicalTrials.gov by Maze Therapeutics on 2025-02-17.